|
| Friday, 12 November 2021, 07:30 HKT/SGT | |
| |  | |
Source: Olympus | |
|
|
|
|
| Initial fund targets medical devices, digital solutions, and diagnostics |
TOKYO, JP & CENTER VALLEY, PA, Nov 12, 2021 - (ACN Newswire) - Olympus Corporation (Tokyo: 7733), a global leader in medical technology, has announced the establishment of Olympus Innovation Ventures to invest in pioneering startups with innovative technologies that improve clinical outcomes, reduce healthcare costs and enhance the quality of life for patients.
Olympus Innovation Ventures, a fully-owned subsidiary of Olympus Corporation of the Americas, is a venture capital fund focused on startups poised to improve patient outcomes, radically advance the detection and treatment of disease, and transform the surgery suite. The new fund expands upon Olympus' strategy to strengthen endoscopy and pioneer next-generation tools and procedures for minimally invasive surgery.
Olympus' venture fund is stage-agnostic, prioritizing early- and growth-stage companies globally with solutions in therapeutic areas including gastroenterology, respiratory, and urology. Olympus has allocated $50 million for initial commitments and follow-on investments in portfolio companies. In addition to capital, Olympus will help its portfolio companies succeed by contributing its clinical and technical expertise, access to healthcare professionals and hospitals, and ability to launch and scale innovative solutions in the global market.
Olympus has been a leader in optical and medical innovation for over 100 years, introducing a mass-produced microscope to Japan in 1919 and the world's first gastrocamera for practical use in 1950. Olympus' tools have aided the minimally invasive surgery revolution and have evolved to detect and treat disease. Yasuo Takeuchi, CEO of Olympus Corporation, says "Our investment underscores our commitment to make people's lives safer, healthier, and more fulfilling. Our goal is for this fund to continue our history of innovation and support our long-term growth and transformation."
Touchdown Ventures, a firm specializing in corporate venture capital, will help manage the Olympus Innovation Ventures fund. Touchdown will work closely with senior executives of Olympus in all aspects of operating the fund.
"We are excited about what Olympus can bring to entrepreneurs through the company's technical strengths, industry relationships, vast distribution, and deep subject matter expertise," noted Scott Lenet, co-founder and President of Touchdown Ventures. "The entire Olympus Innovation Ventures team is working to be the partner of choice for innovators and create a competitive advantage for their startups."
Nacho Abia, Chief Operating Officer of Olympus Corporation, said "This effort is another way Olympus is demonstrating its commitment to excellence and creating tangible value for providers and patients. We believe we will play a meaningful role in the advancement of minimally invasive care and new ways to detect, monitor and treat conditions and diseases."
For more information, please visit http://olympusamerica.com/venture-capital. Olympus Innovation Ventures can be contacted at ventures@olympus.com.
For the contact:
Olympus Corporation of the Americas
Christos Monovoukas
Vice President, Global Business Development
Christos.Monovoukas@Olympus.com
Touchdown Ventures
Deborah Zajac
Director, Investments
deborah@touchdownvc.com
About Olympus
Olympus is passionate about creating customer-driven solutions for the medical, life sciences, and industrial equipment industries. For more than 100 years, Olympus has focused on making people's lives healthier, safer and more fulfilling by helping to detect, prevent, and treat disease; furthering scientific research; and ensuring public safety. As a leading medical technology company, our Medical business uses innovative capabilities in medical technology, therapeutic intervention, and precision manufacturing to help healthcare professionals deliver diagnostic, therapeutic, and minimally invasive procedures to improve clinical outcomes, reduce overall costs, and enhance the quality of life for patients and their safety. Olympus' Medical portfolio includes endoscopes, laparoscopes, and video imaging systems, as well as surgical energy devices, system integration solutions, medical services, and a wide range of endotherapy instruments for endoscopic and therapeutic applications. For more information, visit www.olympus-global.com.
About Touchdown Ventures
Touchdown Ventures partners with corporations to manage their venture capital programs. Touchdown works closely with each corporation to achieve the financial and strategic benefits from venture capital investments. The firm is a Registered Investment Adviser and maintains offices in Los Angeles, Philadelphia, and San Francisco. More information on Touchdown can be found at www.touchdownvc.com
Olympus Contact (Tokyo)
Yuka Horimoto
+81-90-2490-1071
yuka.horimoto@olympus.com
Olympus Contact (USA)
Susan Scerbo
+1-610-909-9153
sue.scerbo@olympus.com
Touchdown Ventures Contact
Deborah Zajac
Director, Investments
+1-917-558-4403
deborah@touchdownvc.com
Topic: Press release summary
Source: Olympus
Sectors: Daily News, BioTech, Healthcare & Pharm, PE, VC & Alternatives, MedTech, Clinical Trials, Startups
http://www.acnnewswire.com
From the Asia Corporate News Network
Copyright © 2024 ACN Newswire. All rights reserved. A division of Asia Corporate News Network.
|
|
|
|
|
|
|
| Olympus |
| Sept 30, 2024 14:00 HKT/SGT |
|
Olympus Launches VISERA S, a New Imaging Platform |
| Sept 20, 2024 14:00 HKT/SGT |
|
Olympus Launches New 4K Camera Head for Urological Endoscopy |
| June 12, 2024 10:00 HKT/SGT |
|
Olympus Enhances Innovation Capabilities by Expanding R&D to Hyderabad, India |
| Mar 27, 2024 14:00 HKT/SGT |
|
NTT and Olympus Begin World's First Joint Demonstration Experiment of Cloud Endoscopy System |
| Jan 24, 2024 14:00 HKT/SGT |
|
Olympus Closes the Acquisition of Korean Gastrointestinal Stent Company, Taewoong Medical Co., Ltd |
| Dec 11, 2023 10:00 HKT/SGT |
|
Olympus Named to Dow Jones Sustainability World Index for Three Consecutive Years |
| Dec 7, 2023 10:00 HKT/SGT |
|
Vesica AI Selected as Winner of Inaugural Olympus Asia Pacific Innovation Program |
| Nov 30, 2023 10:00 HKT/SGT |
|
Olympus's Net-Zero Targets Approved by SBTi |
| Oct 6, 2023 20:00 HKT/SGT |
|
Olympus Names Dr. John de Csepel as Chief Medical Officer |
| July 20, 2023 10:00 HKT/SGT |
|
Olympus to Launch Development Support Project in Kenya for the Diagnosis of Gastrointestinal Diseases |
| More news >> |
 |
|
|
|
